ACOG logo

ACOG
Alpha Cognition Inc

359
Mkt Cap
$149.15M
Volume
4,930.00
52W High
$11.54
52W Low
$4.50
PE Ratio
-5.82
ACOG Fundamentals
Price
$6.96
Prev Close
$6.85
Open
$6.78
50D MA
$5.96
Beta
0.82
Avg. Volume
57,161.50
EPS (Annual)
-$1.18
P/B
2.38
Rev/Employee
$143,947.54
$48.82
Loading...
Loading...
News
all
press releases
Alpha Cognition Strengthens Its Board of Directors with Appointment of Bethany Sensenig
Alpha Cognition Inc. (Nasdaq: ACOG) (Alpha Cognition, or the Company), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today announced the appointment of Bethany Sensenig to its Board of Directors, effective April 15, 2026. Ms...
Business Wire·4d ago
News Placeholder
More News
News Placeholder
Alpha Cognition (NASDAQ:ACOG) Upgraded by Wall Street Zen to "Hold" Rating
Wall Street Zen upgraded Alpha Cognition from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·6d ago
News Placeholder
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Alpha Cognition Inc. (NASDAQ: ACOG) (Alpha Cognition, ACI, or the Company), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today announced...
Business Wire·9d ago
News Placeholder
Alpha Cognition Q1 EPS Forecast Decreased by HC Wainwright
Alpha Cognition Inc. (NASDAQ:ACOG - Free Report) - Analysts at HC Wainwright dropped their Q1 2026 EPS estimates for Alpha Cognition in a research report issued on Wednesday, April 8th. HC Wainwright analyst R. Selvaraju now expects that the company will post earnings of ($0.28) per share for the qu...
MarketBeat·14d ago
News Placeholder
HC Wainwright Estimates Alpha Cognition Q2 Earnings
Alpha Cognition Inc. (NASDAQ:ACOG - Free Report) - Stock analysts at HC Wainwright issued their Q2 2027 earnings per share (EPS) estimates for Alpha Cognition in a research report issued on...
MarketBeat·15d ago
News Placeholder
Alpha Cognition (NASDAQ:ACOG) Lowered to "Sell" Rating by Wall Street Zen
Wall Street Zen lowered Alpha Cognition from a "hold" rating to a "sell" rating in a report on Saturday...
MarketBeat·20d ago
News Placeholder
Alpha Cognition Inc. (ACOG) Soars 8.6%: Is Further Upside Left in the Stock?
Alpha Cognition Inc. (ACOG) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks·22d ago
News Placeholder
Alpha Cognition Receives Issued U.S. Patent for ALPHA-1062 for Treatment of Traumatic Brain Injury
Alpha Cognition Inc. (NASDAQ: ACOG) (Alpha Cognition, ACI, or the Company), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, is pleased to announce the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 12,589,099 on...
Business Wire·23d ago
News Placeholder
Alpha Cognition (ACOG) Q4 2025 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·23d ago
News Placeholder
Alpha Cognition (NASDAQ:ACOG) Posts Earnings Results, Misses Estimates By $0.03 EPS
Alpha Cognition (NASDAQ:ACOG - Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.30) earnings per share for the quarter, missing analysts' consensus...
MarketBeat·27d ago
<
1
2
...
>

Latest ACOG News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.